Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

Table 2 Final diagnosis in symptomatic patients with organic disorders

Organic disorders	s-no-NLH	s-NLH	P value
Diverticular disease	70%	19%	< 0.05
Colon cancer	4%	3%	NS
Infections	3%	24%	< 0.05
IBD	7%	43%	< 0.05
Abdominal adhesions	16%	0%	< 0.05
Others	0%	12%	< 0.05

No-NLH: Patients without evidence of nodular lymphoid hyperplasia; NLH: Patients with evidence of nodular lymphoid hyperplasia; IBD: Inflammatory bowel disease; NS: Not significant. The last column enlists the P value obtained from the comparison between no-NLH and NLH cases, by means of t-test.